Jérémy Godart

Jérémy Godart

Auto-generated profile, based on publicly available information

Jérémy Godart

Erasmus MC Department of Radiotherapy, Dr. Molewaterplein 40, Rotterdam, 3015GD, NETHERLANDS

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Radiotherapy and Oncology
Verified
Journal Article
Open access
DRDominique M.W. Reijtenbagh
Dominique M.W. Reijtenbagh
JGJeremy Godart
Jeremy Godart
JMJan-Willem M. Mens
Jan-Willem M. Mens
SHSabrina T. Heijkoop
Sabrina T. Heijkoop
WHWilma D. Heemsbergen
Wilma D. Heemsbergen
MHMischa S. Hoogeman
Mischa S. Hoogeman
To investigate relationships between patient-reported acute gastro-intestinal symptoms in a locally advanced cervical cancer (LACC) prospective cohort and clinical and dosimetric parameters, while also taking spatial dose into account. A total of 103 patients was included, receiving radiotherapy based on a plan-library-based plan-of-the-day protocol, combined either with concurrent chemotherapy or with neo-adjuvant chemotherapy and concomitant hyperthermia. Toxicity endpoints were extracted from questionnaires sent out weekly during treatment and regularly in the acute phase after treatment. Endpoints were defined for symptoms concerning obstipation, diarrhea, fecal leakage, bowel cramps and rectal bleeding. Dose surface maps were constructed for the rectum. Clinical parameters and dosimetric parameters of the bowel bag and rectum were collected for all patients. The use of concomitant chemotherapy and an increase in Planning Target Volume (PTV) resulted in a significant increase in reported diarrhea. The dose-volume parameters V5Gy-V25Gy of the rectum were found to be significant, unlike dose-volume parameters of the bowel bag. Additionally, a significantly higher dose to the inferior part of the rectum was found for patients reporting diarrhea. No significance was reached for fecal leakage and bowel cramps. The significance of results for patients reporting diarrhea symptoms found for PTV volume indicates a potential benefit for a plan-of-the-day protocol. Additionally, the results suggest that a reduction of inferior rectum dose could decrease patient-reported diarrhea symptoms, while the administration of concomitant chemotherapy appears to lead to radiosensitizing effects that increase these symptoms.

10 June 2025 in Physics in Medicine & Biology
Verified
Journal Article
Open access
PDF file
IAIoannis Androulakis
Ioannis Androulakis
MLMyra van Laar
Myra van Laar
JGJeremy Godart
Jeremy Godart
RSRobin Straathof
Robin Straathof
HWHenrike Westerveld
Henrike Westerveld
IKInger-Karine K Kolkman-Deurloo
Inger-Karine K Kolkman-Deurloo
Objective. In brachytherapy for gynecological cancers using intracavitary applicators, implant reconstruction is commonly performed using applicator libraries. These libraries contain applicator geometry models as well as dwell position (DP) models defined in respect to the applicator geometry. In this study, we investigate whether an afterloader integrated electromagnetic tracking (EMT) system can be utilized for DP model definition and quality assurance in such applicators. Approach. DPs in four sets of two configurations of the Elekta Venezia Advanced Gynaecological Applicator (22 mm ovoids/40 mm intrauterine (IU) and 26 mm ovoids/70 mm IU) were measured using an afterloader integrated EMT system. Measurements were evaluated for reproducibility and compared against manufacturer-specified (MS) DPs and a computed tomography (CT)-corrected DP model. Main Results. Excellent EMT measurement reproducibility was observed, with values of ⩽0.2 mm for both configurations. The overall reproducibility, including applicator geometry reproducibility, was ⩽0.4 mm for both configurations. Significant discrepancies from the manufacturer’s DP model were observed, with a mean ± sd deviation of 1.13 ± 0.66 mm (22/40) and 1.37 ± 0.63 (26/70), particularly in the IU channel, where MS DPs were not experimentally defined. Discrepancies were reduced to 0.89 ± 0.41 mm (22/40) and 0.81 ± 0.33 mm (26/70) when the CT-corrected DP model was used as baseline, highlighting the need for experimentally defined DP models. The overall uncertainty of single measurements was below the clinically acceptable 2 mm limit. Significance. This study confirms that afterloader integrated EMT can accurately reconstruct source paths in gynecological brachytherapy applicators and supports its incorporation into clinical workflows for improved quality assurance and treatment precision. The importance of EMT for quality assurance was highlighted by measured deviations from manufacturer’s DP model in a clinical relevant part of the IU channel.

13 December 2024 in Physics in Medicine & Biology
Verified
Journal Article
Open access
SKSander C Kuipers
Sander C Kuipers
JGJérémy Godart
Jérémy Godart
ENEva M Negenman
Eva M Negenman
ACAnouk Corbeau
Anouk Corbeau
AZAndrás G Zolnay
András G Zolnay
MHMischa S Hoogeman
Mischa S Hoogeman
Objective. This study aims to determine a margin and robustness setting for treating locally advanced cervical cancer (LACC) with a library-of-plans (LoP) based online-adaptive intensity-modulated proton therapy (IMPT). Approach. We analyzed 13 LACC patients with delineated planning and weekly repeat CT scans (reCTs). For each patient, 120 IMPT treatments of 25 fractions were simulated with a LoPs approach. Six different robustness settings (2–7 mm set-up robustness (SR) plus 3% range robustness (RR)) were used to create those 120 IMPT plans. Each fraction was simulated with a weekly reCT, combined with the sampling of inter- and intrafraction treatment uncertainties. The fraction doses were accumulated to obtain a treatment dose to the target volumes, distinguishing between the low-risk clinical target volume (CTV-T-LR) and the elective CTV (CTV-E). If one of the two targets obtained an adequate coverage for more than 90% of the treatments, different anisotropic margins were sampled on top of the robustness setting to the other target to obtain the Pareto-optimal margin in terms of adequate coverage versus increase in target volume. Main results. The percentage of treatments that reach the dose criterion V 42.75Gy > 95% for the CTV-T-LR was 22.3%, 28.5%, 51.2%, 73.1%, 85.3%, and 90.0% for 2, 3, 4, 5, 6, and 7 mm SR plus 3% RR and for the CTV-E, this percentage was 60.4%, 73.8%, 86.5%, 92.3%, 96.9%, and 98.5%. The Pareto-optimal margin combined with a 5 mm/3% robustness setting for the CTV-T-LR with an adequate coverage for >90% of the treatments was given by {0, 1, 0, 3, 3, 0} mm in the left, right, anterior, posterior, cranial, caudal direction. Significance. Our study evaluated combinations of robustness and anisotropic margin settings for IMPT for LACC. With 5 mm SR and 3% RR for CTV-E and CTV-T-LR plus a margin to the CTV-T-LR of {0, 1, 0, 3, 3, 0} mm in left, right, anterior, posterior, cranial, and caudal ensured an adequate coverage for >90% of the simulated IMPT treatments.

29 September 2023 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
SKS. Kuipers
S. Kuipers
ENE. Negenman
E. Negenman
JGJ. Godart
J. Godart
ACA. Corbeau
A. Corbeau
AZA.G. Zolnay
A.G. Zolnay
MHM.S. Hoogeman
M.S. Hoogeman

6 May 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
SOSilje Skjelsvik Os
Silje Skjelsvik Os
TMTrine Martens
Trine Martens
JBJohanna Bluemink
Johanna Bluemink
MBMartin Buschmann
Martin Buschmann
JCJeltsje S. Cnossen
Jeltsje S. Cnossen
ASAnnelen Schmidt
Annelen Schmidt
Background and purposeAdaptive radiotherapy using a Library of Plans (LoP) is widely applied in locally advanced cervical cancer; however, implementation varies across centers, and discrepancies between planned and delivered dose may occur. This study aims to: (1) investigate LoP practices across EMBRACE II centers; (2) simulate contrasting LoP strategies to quantify their dosimetric impact; and (3) compare planned and delivered doses. Materials and methodsSeven EMBRACE II centers reported their LoP practices. Based on these different approaches, two strategies were selected: a simple approach (two plans plus a backup) and a complex approach (plans at 1-cm increments of fundus motion).These strategies were simulated in two patient cases with 3 cm and 8 cm fundus motion using pre-treatment planning CTs.For each fraction, the selected plan was accumulated on the planning CT to estimate the planned dose. Delivered dose was estimated by recalculating each fraction on daily cone-beam CTs followed by deformable accumulation to the planning CT. ResultsLoP practices varied substantially across the seven EMBRACE II centers. For the patient with 3 cm fundus motion, V43 was reduced by 54 cm³ with the simple approach and 44 cm³ with the complex approach, compared to a non-adaptive strategy.For the 8 cm motion case, reductions were 115 cm³ and 167 cm³, respectively.Planned and delivered accumulated doses agreed at lower dose levels but diverged in high-dose regions.ConclusionBoth LoP approaches reduced dose to organs at risk compared with a non-adaptive approach, with greater plan granularity providing additional benefit in patients with large motion. These findings support incorporating LoP strategy details and motion stratification in future EMBRACE II dose–toxicity analyses.

24 July 2023 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
ACA. Corbeau
A. Corbeau
RNR. Nout
R. Nout
SKS. Kuipers
S. Kuipers
EAE. Astreinidou
E. Astreinidou
JMJ.W. Mens
J.W. Mens
SBS. de Boer
S. de Boer